In a previous study, it was found that FK866, a small molecule inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), caused significant metabolic changes in purine metabolism in ovarian cancer and colorectal cancer cells [30]. This evidence concerns the gene NAMPT and ovarian carcinoma.